Guidelines for the Implementation of Drug Utilization Observation (DUO) Studies in Psychopharmacological Therapy
Pharmacopsychiatry 1997 January; 30(1 Supplement): 65-70
Showing items related by title, author, creator and subject.
Guidance for Industry: Postmarketing Studies and Clinical Trials -- Implementation of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act: Drug Safety Unknown author (United States. Department of Health and Human Services; United States. Food and Drug Administration; Center for Biologics Evaluation and Research (U.S.); and Center for Drug Evaluation and Research (U.S.), 2011)